Here’s a concise view of the mefenamic acid market. If you want specific numbers (region, year, CAGR), tell me the region and horizon and I can pull the latest figures.
What is mefenamic acid used for
- An NSAID used for mild-to-moderate pain and particularly effective for dysmenorrhea (menstrual cramps).
- Often sold as a generic, and in many markets it’s available over the counter or with a simple prescription.
Global market status
- Mefenamic acid is a relatively small segment within the overall NSAID market.
- It competes mainly on price in markets where it remains widely used; it faces strong competition from newer and more widely used NSAIDs (ibuprofen, naproxen, diclofenac, etc.).
- In some regions, it’s still a common affordable option; in others, demand has softened due to safety concerns and preference for other NSAIDs.
Regional considerations
- United States: Not marketed today due to historical safety concerns (liver toxicity risks led to withdrawal of Ponstel decades ago).
- Europe, Asia-Pacific, Latin America, and parts of the Middle East: Mefenamic acid is still available in various formulations and dosages, often as a generic.
- Growth drivers vary by region: in some markets, dysmenorrhea treatment keeps demand stable; in others, substitution to other NSAIDs dampens growth.
Key market dynamics
- Growth/tunnel: Generally modest growth or flat to low-single-digit CAGR in many markets, squeezed by safety considerations and competition from other NSAIDs.
- Regulatory landscape: Safety concerns (GI, renal, hepatic risks) and evolving NSAID guidelines influence prescribing/OTC status and may limit uptake.
- Pricing and competition: As a generic analgesic, it’s price-competitive in countries with strong generic markets; in places with strict OTC controls, growth depends on physician prescribing and patient awareness.
What data would help you most?
- Region-specific market size and CAGR (e.g., North America, Europe, Asia-Pacific, Latin America).
- 5-year or 10-year market outlook.
- Competitive landscape (which manufacturers dominate in your target market).
- Regulatory/regulatory status updates (e.g., any countries reclassifying mefenamic acid, safety advisories).
If you want, I can fetch the latest market research figures for a particular region or time frame. Just tell me which region and horizon you’re interested in.